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Sarcomas are rare tumors, mainly stemming from the embryonic mesoderm, with a high grade 
of morbidity and mortality.
Objective: To carry out a retrospective study of head and neck sarcoma cases between 1999 and 
2008 in three specialized centers in the city of Fortaleza.
Materials and Methods: Data collection was based on the charts of the patients in the study. For 
statistical analysis purposes we used the chi-square associations and the z test for proportions.
Results: We found records of 36 patients, and the most affected ones were adult brown males, in the 
age range between 20 and 59 years - mean age of 39.7. The man/woman ratio was 1.76:1. The most 
prevalent histological type was the rhabdomyosarcoma and their most common locations were the 
face and the neck. Most of the sample was made up of live patients without evidence of the disease 
in the last visit - 41.6% of the cases. The most common treatment modes were the combination of 
surgery + radiotherapy + chemotherapy and surgery + radiotherapy, with 27.8% of the cases each.
Conclusion: Sarcomas have a great histological variability and may have numerous locations. Since 
these are rare and not well-known lesions, new epidemiological studies must be carried out in order 
to enhance our understanding of the disease.
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INTRODUCTION
Sarcomas are a very heterogeneous group of rare 
tumors which stem mainly from the embryonic mesoder-
ma1, they may be characterized as tumors stemming mainly 
from bones, cartilage or soft tissue2, such as  fibrous, fat, 
muscular, synovial, vascular or neural tissue3,4. They have 
an incidence of 7,400 new cases and 4,200 deaths per year 
in the US alone5,6, being an important group of tumors 
because of their high morbidity and mortality rates.
Sarcomas represent only 1% of all cancer cases1,7. 
Less than 20% of all sarcomas affect the head and neck 
sites in adults3 and 35% affect pediatric patients. The man/
woman ratio is 1.42:12.
Oral lesions are even rarer. Gorsky and Epstein,3 
in a study on sarcomas and soft tissues, noticed that oral 
sarcomas represented 0.14% of all head and neck can-
cers, which shows how rare these tumors are. Lajer et al.8 
reported from their study that oral sarcomas represented 
27.7% of these head and neck tumors, and Penel et al.9 
reported a 10.7% frequency.
Sarcomas vary considerably in location and histopa-
thological presentation1,3,9. More than 50 histology subtypes 
have been identified1,2. They have a large spectrum of 
clinical activities, varying from a relatively slow growth, to 
an aggressive local and regional growth, with a potential 
do develop systemic metastases10 .
Most head and neck sarcomas involve soft tissue, 
and the hard tissue sarcomas are very rare11, representing 
only 20% of the cases7. The most common histological 
types in the head and neck are the rhabdomyosarcomas, 
followed by malignant histiosarcomas, fibrosarcomas and 
neurofibrosarcomas3.
Head and neck sarcoma treatment is based on 
tumor type, stage, location, size and also patient age. 
Chemotherapy and radiotherapy are the usual combined 
treatment used7,12-14.
Compared to other locations, head and neck sar-
comas have a worse prognosis, since the entire tumor 
removal is impaired by its proximity to vital structures4,15,16, 
which increases the risk of recurrences and functional and 
cosmetic deformities5.
Thanks to its large diversity and rarity, we still know 
very little about sarcomas. Although rare, head and neck 
sarcomas cause high morbidity and mortality, and they 
should be known to all health care professionals, in order 
to have early diagnoses and more efficient treatment. This 
paper aims at contributing to a better understanding of 
this disease, establishing the clinical-pathological profile 
of patients with head and neck sarcomas seen in three 
specialized centers.
MATERIALS AND METHODS
This is a cross-sectional, descriptive study, with 
retrospective data. We included patients with primary 
sarcomas of the head and neck, seen between 1999 and 
2008 in the Head and Neck Surgery Centers of the follo-
wing hospitals: Santa Casa de Misericórdia de Fortaleza, 
Centro Regional Integrado de Oncologia (CRIO) and 
Hospital do Câncer do Ceará.We took off the study those 
patients with Kaposi sarcomas for their clinical differences 
in relation to the other sarcomas, since they are associated 
with type 8 human virus herpes, and also patients with 
incomplete charts.
Patient data were collected from the records of 
head and neck surgeriesand the charts from the assessed 
centers. We studied the following variables: age, gender, 
race, origin, primary anatomical location of the neoplasm, 
pathology diagnosis, type of cancer treatment employed 
and patient status during the most recent medical visit. This 
study was submitted to the Ethics in Research Committee 
of the Hospital do Câncer / Instituto do Câncer do Ceará, 
and it was approved under protocol # 015/09.
The results were plotted in Tables and submitted to 
statistical analysis. We used the chi-square association test 
and the z test for proportions, and a p value lower than 
0.05 was considered statistically significant.
RESULTS
During the study period, we found 51 patients with 
head and neck sarcomas; ten of them were taken out be-
cause they had Kaposi sarcoma, and five because they had 
incomplete charts; thus, the final sample had 36 patients. 
The mean follow up of these patients was of 27.6 months 
(a 1-84 month variation).
Of this sample, 23 (63.9%) were males, and 13 
(36.1%) were females, with a statistically significant di-
fference (p=0.046). The man/woman ratio was 1.76:1. 
As far as age is concerned, the most affected age range 
was between 20 and 59 years, representing 41.6% of the 
cases, as depicted on Table 1; nonetheless, there was no 
statistically significant difference between the age ranges. 
The mean age of the patients was 39.7 (±25.1).
In three (8.3% of the cases), there was no informa-
tion on the patient’s ethnicity. Of the specified total, the 
most affected skin color was brown, with 72.3% of the 
cases, followed by whites, with 27.7%, and the difference 
was statistically significant (p=0.004). There were simila-
rities associated with patient origin, half of them coming 
from the capital city and the other half coming from the 
country side, and we did not have information about the 
origin of one patient (Table 1).
As far as pathology is concerned, we found 12 
histopathological variations of sarcomas, and the most 
common type was the rhabdomyosarcomas, representing 
25% of the cases, followed by the dermatofibrosarcoma 
protuberans and fibrosarcoma, each one with a frequency 
of 13.8%. These diagnoses were settled after histopathology 
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and immunohistochemical analyses in the research centers. 
The most frequent locations were the face and the neck, 
each representing 22.2% of the sarcomas, followed by the 
scalp, with 19.4% of the cases. Intraoral lesions had an 
incidence frequency of 13.8%. Table 2 shows the sample 
distribution as to histological type and tumor location.
On patient status in the last visit, we noticed that 
most of the cases (15, 41.6%) were live patients without 
disease evidence, followed by live patients with local 
disease (nine cases, 25%). The histological type most 
responsible for the higher number of deaths was the 
rhabdomyosarcomas, with four deaths (11.1%), while the 
dermatofibrosarcoma protuberans was the histological type 
with the highest number of live patients with no disease 
evidence, with five cases (13.8%). The face location had 
the highest number of deaths, with five cases (13.8%), and 
the tumor location with the highest number of patients 
without evidence of the disease was the scalp (five cases 
13.8%). The sample distribution as to histological type, 
tumor location and patient status at the last visit  can be 
seen on Table 3.
The most used treatment modes were surgery + ra-
diotherapy + chemotherapy (tem cases, 27.8%) and surgery 
+ radiotherapy (ten cases, 27.8%), as depicted on Table 4.
DISCUSSION
Sarcomas represent a group of very rare diseases, 
with great diversity, which makes it difficult to run sur-
vey studies; thus restricting our knowledge on this type 
of disease.
Literature shows some survey studies involving head 
and neck sarcomas1,3-9,11,12,14-22 which investigate mainly 
patient profile and disease prognostic factors.
In this study, there was a higher prevalence in 
men, with a statistically significant difference, agreeing 
with other studies9,11,16,22. Bentz et al.19 found very similar 
Table 1. Sample characteristics
Variable N %
Age range p=0,756
0-19  11 30,6
20-59 15 41,6
≥ 60 10 27,8
Gender p = 0,046
Female 13 36,1
Male 23 63,9
Ethnicity p = 0,004
 White 9 27,7
 Brown 24 72,3
Origin p = 0,999
Capital 18 50
Countryside 17 47,2
Unspecific 1 2,8
Source: research data
Table 2. Sample distribution according to histology type and location.
Histology type
Location
Total (%)
Face Oral Cavity Scalp Orbit Neck Gnathic bones Parapharyngeal space
Rhabdomyosarcomas 4 1 - 1 3 - - 9 (25)
Dermatofibrosarcoma 1 - 3 - 1 - - 5 (13,8)
Fibrosarcoma - 2 3 - - - - 5 (13,8)
Malignant Fibro-histiocytoma 2 - - - 1 - - 3 (8,3)
Liposarcoma - - - - 3 - - 3 (8,3)
Carcinosarcoma - 1 - 1 - - - 2 (5,6)
Neural sheath sarcoma - - - 2 - - - 2 (5,6)
Osteosarcoma - - - - - 2 - 2 (5,6)
Myxosarcoma 1 - 1 - - - - 2 (5,6)
Ewing Sarcoma - - - 1 - - - 1 (2,8)
Spindle cell Sarcoma - 1 - - - - - 1 (2,8)
Non-classified Sarcoma - - - - - - 1 1 (2,8)
Total 8 5 7 5 8 2 1 36 (100)
Source: study data
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Table 3. Sample distribution according to histological type, location and status in the latest medical visit.
Patient status in the latest visit
Alive without the disease Alive with local disease Alive with metastasis Death
Rhabdomyosarcomas
Dermatofibrosarcoma  1 1 3 4
Fibrosarcoma 5 - - -
Malignant Fibro-histiocytoma 2 2 1 -
Liposarcoma 1 1 - 1
Carcinosarcoma 2 1 - -
Neural sheath sarcoma 1 1 - -
Osteosarcoma - 2 - -
Osteossarcoma 1 - - 1
Ewing Sarcoma - - - 1
Spindle-cell Sarcoma - 1 - -
Myxosarcoma 1 - - 1
Non-classified Sarcoma 1 - - -
Location     
Face 2 1 - 5
Oral cavity 2 2 1 -
Scalp 5 1 1 -
Orbit - 3 1 1
Neck 4 2 1 1
Gnathic bones 1 - - 1
Parapharyngeal space 1 - - -
Source: research data
Table 4. Sample distribution according to treatment and patient status at the latest visit.
Patient status at the latest medical visit
Alive without the disease Alive with local disease Alive with metastasis Death
Treatment
Surgery 6 1 - -
Radiotherapy - - - 1
S+R 6 4 - -
S+C - 1 - -
R+C - 2 1 4
S+R+C 3 1 3 3
Total 15 9 4 8
S=Surgery, R= Radiotherapy, C= Chemotherapy.
Source: research data
prevalence between the genders; and Bree et al.1 found a 
higher frequency among females. The men/women ratio 
found in this study was (1.76:1), similar to what has been 
reported by other authors, such as Le et al.12 and Singh 
et al.22, who found ratios of 1.9:1 and 2:1, respectively.
As far as age is concerned, there was a higher oc-
currence among patients between 20 and 59 years. The 
mean age of the patients was 39.7 (±25.10), similar to what 
was found by Dudhat et al.16, which was of 37 years, and 
the one reported by Gorsky and Epstein11, which was 40.4 
years. In a thorough literature review, including studies 
published between 1972 and 2000, Mendenhall et al.21 
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found mean ages between 50 and 55 years. The literature 
shows that, in the head and neck sarcomas usually affect 
younger patients when compared to the squamous cell 
carcinomas23, including children and teenagers; and risk 
factors such as tobacco have not been associated with 
these tumors3.
The greatest involvement of the brown race in this 
study, representing 72.3% of the cases, can be explained 
by the large mix of ethnics found in northeastern Brazil. 
Arndt and Crist24 showed that the incidence of a specific 
type of sarcoma, the rhabdomyosarcomas, in white chil-
dren is twice that in black children; nonetheless, most 
sarcoma studies do not show associations with skin color.
Noticing a balance between the number of patients 
from the capital city and those coming from the country 
side, we become concerned with the commuting of pa-
tients from the country side in order to have their treatment. 
In developing countries, like Brazil, specialized medical 
care is still short supply in the countryside, patients must 
travel to the capital in order to receive specialized care. We 
also stress that often times the patients must stay in sup-
port public housing, away from their homes and families, 
making their recovery even more difficult. Distance also 
impairs the long term follow up of these patients, whom 
sometimes waive their return visits. Besides the loss in 
treatment and proservation, all these difficulties hamper 
epidemiological studies, which demand long term follow 
up of these patients.
In the present study, we found 12 histopathological 
types of sarcomas, which show the large histological va-
riability of these tumors. The World Health Organization 
defined more than 50 subtypes of sarcomas2. Lajer et al.8 
found a number of patients similar to that of the present 
study (36); however, with 15 histopathology variations. 
The most common subtype in our study was the rhab-
domyosarcomas, representing 25% of the cases, which was 
the same frequency found by Penel et al.9. Other studies 
showed lower prevalence: 8%19, 10%20, 16%4. Dermatofi-
brosarcoma protuberans and fibrosarcoma bear the second 
highest incidence, 13.8% of the cases each. Le et al.12 found 
prevalence of 6% and 15%, respectively for both subtypes.
As far as tumor location is concerned, the face and 
neck are the most affected regions, with 13.8% of the 
cases. Kraus et al.18 also found these two regions as the 
most frequent in the head and neck. Penel et al.9 found a 
greater involvement of the neck, with a frequency of 39.3%.
About patient status in the last visit, it was seen that 
41.6% of the patients were alive and without evidence of 
the disease. This value is similar to the one found by Tran 
et al.5 in a survey involving 164 patients with head and neck 
sarcomas, in which the prevalence of live, disease-free 
patients was of 45.1%. The study from Nasri et al.6 found 
an incidence of 54%, and Huber et al.14 found 50%. In our 
study, live patients with local disease had a prevalence 
of 25%, similar to the findings from Tran5: 21.3%. Death 
happened to 22.2% of the cases, similar to the report from 
Huber14, who found 18.19%. Other older studies showed 
higher death rates, such as those from Tran5, Djkstra15 and 
Kraus18, who found prevalence of 33.5%; 34.5% and 33.3%, 
respectively, which lead us to believe that the progress in 
medicine has improved the prognosis of these patients.
Rhabdomyosarcomas was the histological type that 
had the highest number of deaths (11.1%). This subtype 
of sarcoma has a historically poor prognosis; nonetheless, 
progresses seen in therapy improved substantially the 
clinical outcome of these patients7. Dermatofibrosarcoma 
protuberans type had the highest number of live patients 
without evidence of disease (13.8% of the cases). Accor-
ding to Bree et al.1, this is usually a low grade neoplasm, 
and this classification is done according to the number 
of mitosis, nuclear pleomorphic, necrosis and cellularity. 
Low grade tumors have a better clinical and biological 
behavior, with better response to treatment and better 
prognoses. Sturgis et al.7 stated that the dermatofibrosar-
coma protuberans has a locally aggressive behavior, but 
it usually does not metastasize.
The face represented the tumor location with the 
highest number of deaths (13.8%); and the highest number 
of live patients without the disease was those with scalp 
disease (13.8%). In the head and neck, a factor that really 
impairs sarcoma prognosis is location, since these tumors 
usually invade normal tissue, rendering proper resection 
difficult without causing significant functional and cos-
metic deformities12. Thus, the tumor location impacts the 
selection of surgical options, the potential of obtaining free 
margins and the patient’s functional condition1. This may 
explain the poor prognosis in facial sites; but the number 
of patients in this study and others already published is 
very low to consider location as a prognostic factor.
Since this is a rare disease, it is difficult to establish 
a standard treatment for head and neck sarcomas4. Treat-
ment usually includes multiple treatment modes, especially 
when it is not possible to totally resect the tumor when 
it is near noble anatomical structures10; nonetheless, the 
best treatment option is total tumor resection21. In our 
study, most of the patients were treated with surgery + 
radiotherapy + chemotherapy, representing 27.8% of the 
cases, and surgery + radiotherapy, also with 27.8% of the 
cases. Other authors found lower frequencies; Penel et 
al.9 found 14.2% and 21.4% respectively, and Lajer et al.8, 
16.6% and 13.8%, respectively. Most studies show a large 
frequency of patients who were submitted to surgery only, 
as the studies by Bentz et al.19, with 77% of patients, and 
that of Lajer et al.8, with 52.7%.
CONCLUSIONS
The data in this study show that head and neck 
sarcomas are rare tumors with high histological variability, 
which may involve different anatomical sites. The most 
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affected individuals were brown adult men, in the age 
range between 20 and 59, with mean age of 39.7. The 
predominant histological type was the rhabdomyosarco-
mas and the most common locations were the face and 
the neck. Most of the patients were live without evidence 
of disease in the last visit. The most common treatment 
modes were the combination of surgery + radiotherapy 
+ chemotherapy and surgery + radiotherapy. Since these 
are rare and not well-known lesions, new epidemiological 
studies must be carried out, in order to provide us with 
more knowledge about the disease.
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